Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.85 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL913237 | 0.98 | TDP1 (0.81) | TDP1LMNAALDH1A1MAPK1HIF1A | |
| SCHEMBL11896258 | 0.98 | TDP1 (0.81) | TDP1LMNAALDH1A1MAPK1HIF1A | |
| SCHEMBL11896278 | 0.98 | TDP1 (0.81) | TDP1LMNAALDH1A1MAPK1HIF1A | |
| SCHEMBL10790013 | 0.98 | TDP1 (0.81) | TDP1LMNAALDH1A1MAPK1HIF1A | |
| SCHEMBL6821603 | 0.98 | TDP1 (0.81) | TDP1LMNAALDH1A1MAPK1HIF1A | |
| SCHEMBL9712789 | 0.98 | TDP1 (0.81) | TDP1LMNAALDH1A1MAPK1HIF1A | |
| SCHEMBL7295237 | 0.98 | TDP1 (0.81) | TDP1LMNAALDH1A1MAPK1HIF1A | |
| SCHEMBL14723101 | 0.98 | TDP1 (0.81) | TDP1LMNAALDH1A1MAPK1HIF1A | |
| SCHEMBL28067101 | 0.98 | TDP1 (0.81) | TDP1LMNAALDH1A1MAPK1HIF1A | |
| Potassium SCHEMBL29767441 | 0.96 | TDP1 (0.79) | TDP1LMNAALDH1A1MAPK1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105001298-B | A kind of synthesis isolation and purification method of indissoluble polypeptide | 南京斯拜科生化实业有限公司 | 2018-01-02 | — | — | CN | claimed |
| US-8519085-B2 | Coating compositions for containers and methods of coating | VALSPAR SOURCING, INC. (US) | 2013-08-27 | — | — | US | claimed |
| US-20120116048-A1 | Coating Compositions for Containers and Methods of Coating | VALSPAR SOURCING, INC. (US) | 2012-05-10 | — | — | US | claimed |
| EP-1937434-A2 | COATING COMPOSITIONS FOR CONTAINERS AND METHODS OF COATING | Valspar Sourcing, Inc. (US) | 2008-07-02 | — | — | EP | claimed |
| WO-2007048094-A2 | COATING COMPOSITIONS FOR CONTAINERS AND METHODS OF COATING | VALSPAR SOURCING, INC. (US) | 2007-04-26 | — | — | WO | claimed |
| US-20070087146-A1 | Coating Compositions for Containers and Methods of Coating | VALSPAR SOURCING, INC. (US) | 2007-04-19 | — | — | US | claimed |
| US-4656214-A | DIESTERS | EXXON RESEARCH & ENGINEERING CO. (US) | 1987-04-07 | — | — | US | claimed |
| CN-119842650-A | Acyltransferase for synthesizing polyester intermediate and application thereof | 中国科学院天津工业生物技术研究所 | 2025-04-18 | — | — | CN | disclosed |
| US-20240360121-A1 | GLS1 INHIBITORS FOR TREATING DISEASE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2024-10-31 | — | — | US | disclosed |
| US-11958849-B2 | GLS1 inhibitors for treating disease | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-04-16 | — | — | US | disclosed |
| EP-1937434-B1 | COATING COMPOSITIONS FOR CONTAINERS AND METHODS OF COATING | SWIMC LLC (US) | 2023-12-06 | — | — | EP | disclosed |
| US-20230242480-A1 | Alkyne Compound, Vitamin D Compound, Analytical Method, and Production Method | JEOL LTD. (JP) | 2023-08-03 | — | — | US | disclosed |
| EP-3778809-B1 | COATING COMPOSITIONS FOR CANS AND METHODS OF COATING | SWIMC LLC (US) | 2023-04-26 | — | — | EP | disclosed |
| US-4798842-A | Inhibitors of slow reacting substance of anaphylaxis | SCHERING CORPORATION (US) | 1989-01-17 | — | — | US | disclosed |
| US-4758594-A | Inhibitors of slow reacting substance of anaphylaxis | SCHERING CORPORATION (US) | 1988-07-19 | — | — | US | disclosed |
| US-4696946-A | Topical Treatment of hyperproliferative skin diseases | SCHERING CORPORATION (US) | 1987-09-29 | — | — | US | disclosed |
| EP-0169033-A2 | Inhibitors of slow reacting substance of anaphylaxis | SCHERING CORPORATION (US) | 1986-01-22 | — | — | EP | disclosed |
| EP-0146880-A2 | Copolyester-carbonate resins exhibiting improved processability | GENERAL ELECTRIC COMPANY (US) | 1985-07-03 | — | — | EP | disclosed |
| US-4487917-A | ENGINEERING THERMOPLASTICS | GENERAL ELECTRIC COMPANY (US) | 1984-12-11 | — | — | US | disclosed |
| US-4017524-A | PRINTING AND DYEING OF SYNTHETIC FIBERS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240360121-A1 | GLS1 INHIBITORS FOR TREATING DISEASE | GLS2, GLS, GLG1 | TDP1 2403/4885LMNA 3276/4885ALDH1A1 882/4885 |
| US-11958849-B2 | GLS1 inhibitors for treating disease | GLS2, GLS, GLG1 | TDP1 2403/4885LMNA 3276/4885ALDH1A1 882/4885 |
| US-20230242480-A1 | Alkyne Compound, Vitamin D Compound, Analytical Method, and Production Method | VDR, CYP2R1, CYP24A1 | TDP1 4878/4885LMNA 1250/4885ALDH1A1 452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.